<code id='1FC03F7E9F'></code><style id='1FC03F7E9F'></style>
    • <acronym id='1FC03F7E9F'></acronym>
      <center id='1FC03F7E9F'><center id='1FC03F7E9F'><tfoot id='1FC03F7E9F'></tfoot></center><abbr id='1FC03F7E9F'><dir id='1FC03F7E9F'><tfoot id='1FC03F7E9F'></tfoot><noframes id='1FC03F7E9F'>

    • <optgroup id='1FC03F7E9F'><strike id='1FC03F7E9F'><sup id='1FC03F7E9F'></sup></strike><code id='1FC03F7E9F'></code></optgroup>
        1. <b id='1FC03F7E9F'><label id='1FC03F7E9F'><select id='1FC03F7E9F'><dt id='1FC03F7E9F'><span id='1FC03F7E9F'></span></dt></select></label></b><u id='1FC03F7E9F'></u>
          <i id='1FC03F7E9F'><strike id='1FC03F7E9F'><tt id='1FC03F7E9F'><pre id='1FC03F7E9F'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:comprehensive    Page View:6
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In